Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision number updated from v3.6.2 to v3.6.3, indicating a small page update; the visible study information appears unchanged.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating an updated version of the study details page. This likely reflects backend or formatting updates rather than changes to the trial information.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now indicates that recruitment has ended and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also shows a revision stamp (Revision: v3.6.0) and updates the Intervention/Treatment label formatting.SummaryDifference0.5%

- Check39 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor release of the page's underlying system.SummaryDifference0.1%

- Check60 days agoChange DetectedThe revision tag was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's revision history. This does not reflect changes to the study details or results.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor platform/content release change without altering the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.